Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Gilde Healthcare acquires stake in Swiss Dental Solutions

Capital investor Gilde Healthcare acquires a majority stake in Swiss Dental Solutions (SDS) through its private equity fund. SDS aims to accelerate its growth in both Europe and the US and become a world leader in the emerging market of ceramic dental implants.

Max Healthcare expands footprint in India

Indian hospital group Max Healthcare is expanding its footprint through a 100% stake acquisition in the Starlit Medical Centre for RS 940 crore ($112.8m). The acquisition gives Max full ownership of the 17-storey, 550-bed Sahara Hospital - located in the city of Lucknow - on a slump-sale basis.

Cigna and Humana deal off

Contrary to speculation that a deal would be announced by Christmas, two of the largest health insurers in the US - Cigna and Humana - will not be merging to form a $140bn giant insurer. After reportedly failing to agree on a price, Cigna is instead reportedly planning to buy back $10bn worth of shares.

Operose set to sell

Primary care group Operose is being sold to HCRG Care Group, a UK healthcare provider. It is the last of the three major Europe-based groups to be sold off by US insurance company Centene.

Two French imaging groups invested in by PE

Two medium-sized French imaging operators, X-Ray Phocea and Cardinet, have been invested in by private equity firms, in what could be a signal that the long-awaited consolidation of France's imaging sector is about to take off.

Affidea solidifies presence in Spain and Romania

Pan-European imaging and diagnostic firm Affidea is expanding in Spain and Romania. Its acquisitions of Clinica Atenea in Valencia and Odelga Imagistics clinic in Bucharest bring the number of Affidea’s centers in Europe to 340, cementing its influence in the region.

Aster DM sells majority stake in Gulf business for $1bn

Dubai-based listed hospital and pharmacy chain Aster DM is selling a majority 65% stake in its Gulf business for a shade over $1bn to a consortium led by PE investor Fajr Capital. HBI investigates the thinking behind the deal, what this means for the group's expansion plans, and looks at the future of the GCC market generally with the help of expert commentary. 

Find Us